Atlas Trials

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Clinical trial NCT03854617 · UNKNOWN

Trial details

NCT number
NCT03854617
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Start date
2019-02-20
Primary completion
2021-12-20
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.